Kaskela Law LLC Announces Shareholder Investigation of Fate Therapeutics, Inc. (NASDAQ: FATE) and Encourages Long-Term FATE Shareholders to Contact the Firm
September 19, 2024 08:00 ET
|
Kaskela Law
PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Fate Therapeutics, Inc. (NASDAQ: FATE) (“Fate”) on behalf of the company’s long-term shareholders....
Kaskela Law LLC Announces Shareholder Investigation of Dentsply Sirona Inc. (NASDAQ: XRAY) and Encourages Long-Term XRAY Shareholders to Contact the Firm
September 19, 2024 08:00 ET
|
Kaskela Law
PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Dentsply Sirona Inc. (NASDAQ: XRAY) (“Dentsply”) on behalf of the company’s long-term...
CorMedix Inc. Announces New Commercial Agreement
September 19, 2024 08:00 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Sept. 19, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and...
SINTX Announces Completion of $3.1 Million ATM Equity Public Offering
September 19, 2024 08:00 ET
|
SINTX Technologies, Inc.
Salt Lake City, Utah, Sept. 19, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) a leading innovator in ceramic manufacturing, today announced the...
Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Long-Term NARI Shareholders to Contact the Firm
September 19, 2024 08:00 ET
|
Kaskela Law
PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Inari Medical, Inc. (NASDAQ: NARI) on behalf of the company’s long-term shareholders. ...
IT Nation Introduces New IT Nation Torch Award Program for 2024 Flagship Event
September 19, 2024 08:00 ET
|
IT Nation
TAMPA, Fla., Sept. 19, 2024 (GLOBE NEWSWIRE) -- IT Nation, a global community of peers, thought leaders, and experts dedicated to elevating the IT ecosystem to new heights, has announced its new...
Kaskela Law LLC Announces Shareholder Investigation of Globe Life Inc. (NYSE: GL) and Encourages Long-Term GL Shareholders to Contact the Firm
September 19, 2024 08:00 ET
|
Kaskela Law
PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Globe Life Inc. (NYSE: GL), formerly known as Torchmark Corp., on behalf of the company’s...
AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
September 19, 2024 08:00 ET
|
AIM ImmunoTech Inc.
Preliminary finding of stable disease in two out of three patients at 6 months in the first subject cohort Combination of Ampligen and Imfinzi continues to be generally well-tolerated with no...
Kaskela Law LLC Announces Shareholder Investigation of Doximity, Inc. (NYSE: DOCS) and Encourages Long-Term DOCS Shareholders to Contact the Firm
September 19, 2024 08:00 ET
|
Kaskela Law
PHILADELPHIA, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Doximity, Inc. (NYSE: DOCS) on behalf of the company’s long-term shareholders. Recently a...
Humacyte Announces Allowance of U.S. Patent Covering BioVascular Pancreas (BVP™)
September 19, 2024 08:00 ET
|
Humacyte, Inc
- New U.S. patent covers the design and composition of the BVP - - Positive results from ongoing preclinical studies support the potential of the BVP to deliver insulin-producing islets as a...